Viewing Study NCT00052559


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-06-16 @ 8:49 PM
Study NCT ID: NCT00052559
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 2003-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2012-02908
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators